DE69913351D1 - Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen - Google Patents
Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlenInfo
- Publication number
- DE69913351D1 DE69913351D1 DE69913351T DE69913351T DE69913351D1 DE 69913351 D1 DE69913351 D1 DE 69913351D1 DE 69913351 T DE69913351 T DE 69913351T DE 69913351 T DE69913351 T DE 69913351T DE 69913351 D1 DE69913351 D1 DE 69913351D1
- Authority
- DE
- Germany
- Prior art keywords
- shielding
- metal complexes
- chlorine derivatives
- ray rays
- ray
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0085—Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/545—Heterocyclic compounds
- A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19571798 | 1998-07-10 | ||
JP19571798 | 1998-07-10 | ||
PCT/JP1999/003752 WO2000002882A1 (fr) | 1998-07-10 | 1999-07-12 | Nouveaux complexes metalliques intercepteurs de rayons x a base de derives de chlore |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69913351D1 true DE69913351D1 (de) | 2004-01-15 |
DE69913351T2 DE69913351T2 (de) | 2004-09-16 |
Family
ID=16345803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69913351T Expired - Lifetime DE69913351T2 (de) | 1998-07-10 | 1999-07-12 | Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen |
Country Status (9)
Country | Link |
---|---|
US (1) | US6413495B1 (de) |
EP (1) | EP1097935B1 (de) |
JP (1) | JP3692298B2 (de) |
AT (1) | ATE255583T1 (de) |
AU (1) | AU748625B2 (de) |
CA (1) | CA2336582C (de) |
DE (1) | DE69913351T2 (de) |
ES (1) | ES2212577T3 (de) |
WO (1) | WO2000002882A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE386514T1 (de) * | 1999-04-02 | 2008-03-15 | Meiji Seika Kaisha | Inhibition der vaskulären restenose nach einer angioplastie |
EP1363548B1 (de) | 2000-11-24 | 2015-08-12 | Koninklijke Philips N.V. | Vorrichtung zur diagnostizierung, bilderzeugung und medizinischen intervention |
EP1351619A4 (de) | 2001-01-16 | 2011-01-05 | Microdexterity Systems Inc | Chirurgischer manipulator |
IL147898A (en) * | 2002-01-30 | 2007-05-15 | Yuval Golan | A method of treating cancer based on the Ugar effect |
US10376711B2 (en) * | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
CN2885311Y (zh) | 2006-01-18 | 2007-04-04 | 郑成福 | 经尿道光动力疗法前列腺治疗仪 |
JP4960602B2 (ja) * | 2005-04-15 | 2012-06-27 | 三鷹光器株式会社 | 蛍光観察時の明視野光源及びそれを搭載した手術顕微鏡 |
AU2009347929A1 (en) * | 2009-06-12 | 2012-01-19 | Amrita Vishwa Vidyapeetham University | Targeted nano-photomedicines for photodynamic therapy of cancer |
RU2455039C1 (ru) * | 2011-03-14 | 2012-07-10 | Виктор Александрович Борисов | Способ фотодинамической терапии злокачественных новообразований |
CA2907356C (en) | 2013-03-15 | 2022-07-12 | Sherri Ann MCFARLAND | Metal-based coordination complexes as photodynamic compounds and their use |
US10149493B2 (en) | 2015-04-29 | 2018-12-11 | Corn Products Development, Inc. | Flours that improve the crispness of battered potatoes |
AU2016326737B2 (en) | 2015-09-24 | 2023-01-12 | Abvitro Llc | Affinity-oligonucleotide conjugates and uses thereof |
PL236093B1 (pl) | 2017-07-04 | 2020-11-30 | Dominika Szczepaniak | Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie |
PL244960B1 (pl) | 2021-02-15 | 2024-04-08 | Dominika Szczepaniak | Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4693885A (en) * | 1984-07-18 | 1987-09-15 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
GB8426102D0 (en) * | 1984-10-16 | 1984-11-21 | Ici Plc | Thermal transfer printing |
US4921973A (en) * | 1984-12-10 | 1990-05-01 | Johnson Matthey Inc. | Platinum complexes and the like |
US4815447A (en) * | 1985-03-19 | 1989-03-28 | Mills Randell L | Mossbauer cancer therapy |
US4656186A (en) * | 1985-04-30 | 1987-04-07 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
DE3827940A1 (de) * | 1988-08-13 | 1990-03-01 | Schering Ag | 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
JP3253663B2 (ja) * | 1992-01-20 | 2002-02-04 | タマ生化学株式会社 | 放射線増感剤 |
-
1999
- 1999-07-12 AU AU46510/99A patent/AU748625B2/en not_active Ceased
- 1999-07-12 US US09/743,448 patent/US6413495B1/en not_active Expired - Lifetime
- 1999-07-12 JP JP2000559112A patent/JP3692298B2/ja not_active Expired - Fee Related
- 1999-07-12 AT AT99929792T patent/ATE255583T1/de not_active IP Right Cessation
- 1999-07-12 DE DE69913351T patent/DE69913351T2/de not_active Expired - Lifetime
- 1999-07-12 CA CA002336582A patent/CA2336582C/en not_active Expired - Lifetime
- 1999-07-12 WO PCT/JP1999/003752 patent/WO2000002882A1/ja active IP Right Grant
- 1999-07-12 EP EP99929792A patent/EP1097935B1/de not_active Expired - Lifetime
- 1999-07-12 ES ES99929792T patent/ES2212577T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3692298B2 (ja) | 2005-09-07 |
EP1097935A1 (de) | 2001-05-09 |
CA2336582C (en) | 2006-06-06 |
EP1097935A4 (de) | 2002-01-30 |
US6413495B1 (en) | 2002-07-02 |
CA2336582A1 (en) | 2000-01-20 |
ES2212577T3 (es) | 2004-07-16 |
ATE255583T1 (de) | 2003-12-15 |
AU748625B2 (en) | 2002-06-06 |
AU4651099A (en) | 2000-02-01 |
WO2000002882A1 (fr) | 2000-01-20 |
EP1097935B1 (de) | 2003-12-03 |
DE69913351T2 (de) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69913351D1 (de) | Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen | |
NO20006155D0 (no) | Texaphyrinkonjugater og anvendelse derav | |
RU92016479A (ru) | Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких | |
NO20040239L (no) | Konjugater av makrosykliske metallkomplekser med biomolekyler og anvendelse derav til fremstilling av midler for anvendelse i NMR- og røntgendiagnose, samt ved strålebehandling | |
DE3751809D1 (de) | Intraoperative erstellung des befundes und tumor-therapie mittels endoskop | |
RU93051543A (ru) | Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей | |
TR200003879T2 (tr) | İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@ | |
MY121548A (en) | Compounds and methods for the treatment of cancer | |
AU6198086A (en) | Agents for use in tumour diagnosis, imaging, localization or treatment | |
NO994932L (no) | Blandinger og fremgangsmåter for behandling og diagnose av brystkreft | |
ATE262515T1 (de) | Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie | |
ATE306281T1 (de) | Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs | |
GB2393123A (en) | Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy | |
IL97055A0 (en) | Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives | |
DE68926913D1 (de) | Chelatbildende Verbindungen, die eine ortho-bindende Gruppe besitzen und ihre Komplexe | |
MX9200413A (es) | Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando. | |
DK0730871T3 (da) | Radioaktivt kompleks og anvendelsen heraf til strålebehandling | |
NO995109L (no) | Formuleringer inneholdende 1,2,4-benzotriazinoksyder | |
TR200102576T2 (tr) | Kanser tedavisinde radyoaktif sisplatin | |
SE8505315D0 (sv) | Anordning for stralfeltsavskermning vid radioterapi | |
DK1154798T3 (da) | Molekyler til behandling og diagnose af tumorer | |
Oren et al. | Exposure to ultraviolet B radiation during phototherapy. | |
GR880100589A (en) | Metalloporfyrines for the inversion of the toxic activity for the tumors treatment | |
ATE291620T1 (de) | Mammakarzinom-assoziiertes gen | |
AU8436791A (en) | Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1097935 Country of ref document: EP Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE |